These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11555547)

  • 1. Cough in a patient with an infusion port.
    Wong C; Joshi N; Nachimuthu S; Vaka G; Bakoss J
    Chest; 2001 Sep; 120(3):1031-3. PubMed ID: 11555547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic spread from squamous cell carcinoma of the hypopharynx to the totally implantable venous access port insertion site: Case report and review of literature.
    Mangla A; Agarwal N; Mullane MR
    Head Neck; 2017 Dec; 39(12):E118-E122. PubMed ID: 28990283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of chemotherapy does not affect complications with an implantable venous access device.
    Brown DF; Muirhead MJ; Travis PM; Vire SR; Weller J; Hauer-Jensen M
    Cancer; 1997 Sep; 80(5):966-72. PubMed ID: 9307199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update on implantable chambers].
    Nahum S
    Soins Gerontol; 2006; (61):17-20. PubMed ID: 17063848
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma].
    Ryuko K; Iwanari O; Moriyama M; Moriyama M; Nakayama S; Miyako J; Kitao M
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):2052-7. PubMed ID: 1877848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy.
    Poorter RL; Lauw FN; Bemelman WA; Bakker PJ; Taat CW; Veenhof CH
    Eur J Cancer; 1996 Dec; 32A(13):2262-6. PubMed ID: 9038608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior vena cava syndrome during chemotherapy for stage 3c fallopian tube adenocarcinoma.
    Griffin D; Martino MA; Hoffman MS
    Gynecol Oncol; 2004 Apr; 93(1):257-9. PubMed ID: 15047247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urokinase recanalization of extensive thrombosis of the superior vena cava secondary to an implantable perfusion device].
    Gueunoun M; Ebagosti A; Favre R; Touboul-Gueunoun E; Levy S
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1913-6. PubMed ID: 2514647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy drug extravasation in totally implantable venous access port systems: use of subcutaneous wash-out technique (with vidéo)].
    Taibi A; Ferrero PA; Derbal S
    Gynecol Obstet Fertil Senol; 2020 Apr; 48(4):398-399. PubMed ID: 31991173
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case report of the fallopian tubal carcinoma successfully treated with intraperitoneal chemotherapy using a subcutaneously implanted reservoir].
    Okamoto A; Hayashi D; Hashimoto N
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Nov; 44(11):1451-4. PubMed ID: 1281206
    [No Abstract]   [Full Text] [Related]  

  • 12. Doxil extravasation injury: a case report.
    Lokich J
    Ann Oncol; 1999 Jun; 10(6):735-6. PubMed ID: 10442200
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bowel injury caused by a catheter for Intraperitoneal chemotherapy--a case report].
    Yamauchi I; Higashi M; Yoshioka M; Koyama N; Hashimoto M; Takahashi K; Nakamura Y
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1713-6. PubMed ID: 8886051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of nursing in the prevention of complications of totally implantable venous access devices].
    Di Carlo I; Toro A; Fasone A; Barbagallo F; Di Stefano A; Cordio S; Russello D
    G Chir; 2003 Apr; 24(4):133-5. PubMed ID: 12886752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
    Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin sheath formation and chemotherapy extravasation: a case report.
    Mayo DJ
    Support Care Cancer; 1998 Jan; 6(1):51-6. PubMed ID: 9458537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port].
    Kondo N; Tomita M; Hasegawa N; Kazama A
    Hinyokika Kiyo; 1999 Jun; 45(6):443-5. PubMed ID: 10442291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extravasation of cytostatics. Example of a severe complication from the use of long-term central venous catheters].
    Bach F; Videbaek C; Holst-Christensen J; Boesby S
    Ugeskr Laeger; 1991 Oct; 153(41):2896-7. PubMed ID: 1949309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable venous port-related infections in cancer patients.
    Huang WT; Chen TY; Su WC; Yen CJ; Tsao CJ
    Support Care Cancer; 2004 Mar; 12(3):197-201. PubMed ID: 14727170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venopulmonary fistula: a rare complication of central venous catheterization.
    Demey HE; Colemont LJ; Hartoko TJ; Roodhooft AI; Ysebaert DK; Bossaert LL
    JPEN J Parenter Enteral Nutr; 1987; 11(6):580-2. PubMed ID: 3123728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.